Enterome Bioscience
Rodolphe CLERVAL
Chief Business Officer
Who are we?
ENTEROME is pioneering the development of novel pharmaceuticals and diagnostics to support personalized therapies in microbiome-related diseases such as Inflammatory Bowel Disease (IBD) and cancer. Enterome is also leading the development of new industry standards in gut microbiome quantitative and functional analysis. This technology leadership allows Enterome to open up the new field of therapeutic target discovery in the microbiome in order to address significant unmet medical needs. Enterome has established partnerships with leading pharmaceutical companies, including J&J Innovation/Janssen Biotech, and Takeda in IBD; and BMS in immuno-oncology.